In some types of cancer, CK1α seems to exhibit oncogenic features by promoting proliferation, genome instability and inhibition of apoptotic processes, such as ovarian cancer,26 acute myelocytic leukemia27 and so on, which are supported by the fact that CK1α is often overexpressed in those tumors and correlates with poor survival. Here, CSNK1A1 is linked to ovarian carcinoma.